A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Clinical trial NCT07297212 · RECRUITING

Trial details

NCT number: NCT07297212
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2026-01-15
Primary completion: 2028-01-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.